2021 NCHHSTP Newsroom Releases
This page includes all of the materials released to the press during the course of the calendar year. Previous releases are also available by year. In addition to providing all releases in reverse chronological order, these materials are also organized by topic area (i.e. HIV, STD, TB, viral hepatitis and healthy youth).
2021 News & Announcements
New CDC Vital Signs report reveals a decade of continuing HIV inequities – November 30, 2021
Despite overall progress in reducing new infections among gay and bisexual men, the HIV epidemic continued and was more severe among Black and Hispanic/Latino gay and bisexual men in the decade leading up to the federal Ending the HIV Epidemic in the U.S. initiative.
Press Statement | Comunicado de Prensa | MMWR | Graphics | Vital Signs
New estimates reveal declines in hepatitis C treatment initiation in the U.S. – November 8, 2021
CDC’s first estimates of hepatitis C treatment, presented at the 2021 American Association of the Study of Liver Disease (AASLD) meeting, show the number of people living with hepatitis C in the U.S. who initiated treatment with direct-acting antiviral agents (DAA) declined from 2015 to 2020.
CDC Awards $117 Million to Advance Innovation and Health Equity in Federal Initiative to End HIV – July 27, 2021
CDC awarded $117 million to state and local health departments to help rebuild and begin to expand HIV prevention and treatment efforts as the U.S. continues to respond to COVID-19. The awards are part of the federal Ending the HIV Epidemic in the U.S. (EHE) initiative, which funds 57 priority areas to expand and tailor key HIV prevention strategies to community needs.
Press Release | Comunicado de Prensa | State/Local Funding Table
Reported STDs in the U.S. dropped then resurged during the COVID-19 pandemic – July 16, 2021
New CDC data show that during March-April 2020, reported STD cases dramatically decreased compared to the same time in 2019. However, a resurgence in gonorrhea and syphilis cases later in the year suggest overall STDs may have increased during 2020.
Hopeful signs of progress in HIV prevention, but gains remain uneven – May 27, 2021
New CDC data show new HIV infections fell 8% from 2015 to 2019, after a period of general stability in new infections in the U.S. These data suggest recent progress is likely due to increased uptake of key prevention and treatment strategies. However, to reach the Ending the HIV Epidemic in the U.S goals, addressing continued disparities will be crucial.
Transgender Women Urgently Need More HIV Prevention and Treatment Services – April 15, 2021
A CDC report released in advance of National Transgender HIV Testing Day found that four in ten transgender women surveyed in seven major U.S. cities have HIV. These findings demonstrate the pressing need for scaled-up HIV prevention and care strategies for transgender women.
Reported STDs reach all-time high for 6th consecutive year – April 13, 2021
New CDC data show that reported annual cases of STDs in the United States continued to climb in 2019, reaching an all-time high for the sixth consecutive year.
Press Release | Comunicado de Prensa | Full Report | Fact Sheet | Graphics
Progress Toward Tuberculosis Elimination Has Slowed in Recent Years – March 25, 2021
Although TB cases have fallen steadily since 1993, progress toward elimination has recently slowed and the COVID-19 pandemic has further strained TB prevention and control services.
Media Summary | MMWR | Graphics | Fact Sheet
2021 Conference on Retroviruses and Opportunistic Infections – March 6-10, 2021
CDC scientists will present nearly 30 abstracts at the 2021 Conference on Retroviruses and Opportunistic Infections (CROI). The conference will be held virtually from March 6-10, 2021. Several studies that may be of particular interest represent two main research areas: COVID-19’s impact on HIV testing and treatment, and disparities among people with HIV.
1 in 5 people in the U.S. have a sexually transmitted infection – January 25, 2021
New data estimate that on any given day in 2018, 1 in 5 people in the U.S. had a sexually transmitted infection (STI). CDC analyses, published in the journal Sexually Transmitted Diseases, show the burden of diagnosed and undiagnosed STIs in the U.S., and the estimated medical costs associated with STIs.
New CDC Vital Signs report reveals a decade of continuing HIV inequities – November 30, 2021
Despite overall progress in reducing new infections among gay and bisexual men, the HIV epidemic continued and was more severe among Black and Hispanic/Latino gay and bisexual men in the decade leading up to the federal Ending the HIV Epidemic in the U.S. initiative.
Press Statement | Comunicado de Prensa | MMWR | Graphics | Vital Signs
CDC Awards $117 Million to Advance Innovation and Health Equity in Federal Initiative to End HIV – July 27, 2021
CDC awarded $117 million to state and local health departments to help rebuild and begin to expand HIV prevention and treatment efforts as the U.S. continues to respond to COVID-19. The awards are part of the federal Ending the HIV Epidemic in the U.S. (EHE) initiative, which funds 57 priority areas to expand and tailor key HIV prevention strategies to community needs.
Press Release | Comunicado de Prensa | State/Local Funding Table
Hopeful signs of progress in HIV prevention, but gains remain uneven – May 27, 2021
New CDC data show new HIV infections fell 8% from 2015 to 2019, after a period of general stability in new infections in the U.S. These data suggest recent progress is likely due to increased uptake of key prevention and treatment strategies. However, to reach the Ending the HIV Epidemic in the U.S goals, addressing continued disparities will be crucial.
Transgender Women Urgently Need More HIV Prevention and Treatment Services – April 15, 2021
A CDC report released in advance of National Transgender HIV Testing Day found that four in ten transgender women surveyed in seven major U.S. cities have HIV. These findings demonstrate the pressing need for scaled-up HIV prevention and care strategies for transgender women.
2021 Conference on Retroviruses and Opportunistic Infections – March 6-10, 2021
CDC scientists will present nearly 30 abstracts at the 2021 Conference on Retroviruses and Opportunistic Infections (CROI). The conference will be held virtually from March 6-10, 2021. Several studies that may be of particular interest represent two main research areas: COVID-19’s impact on HIV testing and treatment, and disparities among people with HIV.
Reported STDs in the U.S. dropped then resurged during the COVID-19 pandemic – July 16, 2021
New CDC data show that during March-April 2020, reported STD cases dramatically decreased compared to the same time in 2019. However, a resurgence in gonorrhea and syphilis cases later in the year suggest overall STDs may have increased during 2020.
Reported STDs reach all-time high for 6th consecutive year – April 13, 2021
New CDC data show that reported annual cases of STDs in the United States continued to climb in 2019, reaching an all-time high for the sixth consecutive year.
Press Release | Comunicado de Prensa | Full Report | Fact Sheet | Graphics
1 in 5 people in the U.S. have a sexually transmitted infection – January 25, 2021
New data estimate that on any given day in 2018, 1 in 5 people in the U.S. had a sexually transmitted infection (STI). CDC analyses, published in the journal Sexually Transmitted Diseases, show the burden of diagnosed and undiagnosed STIs in the U.S., and the estimated medical costs associated with STIs.
Progress Toward Tuberculosis Elimination Has Slowed in Recent Years – March 25, 2021
Although TB cases have fallen steadily since 1993, progress toward elimination has recently slowed and the COVID-19 pandemic has further strained TB prevention and control services.
Media Summary | MMWR | Graphics | Fact Sheet
New estimates reveal declines in hepatitis C treatment initiation in the U.S. – November 8, 2021
CDC’s first estimates of hepatitis C treatment, presented at the 2021 American Association of the Study of Liver Disease (AASLD) meeting, show the number of people living with hepatitis C in the U.S. who initiated treatment with direct-acting antiviral agents (DAA) declined from 2015 to 2020.
Browse 2020 News Releases
